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Abstract
The genomic profile underlying an individual tumor can be highly informative
in the creation of a personalized cancer treatment strategy for a given patient; a
practice known as precision oncology. This involves next generation sequencing
of a tumor sample and the subsequent identification of genomic aberrations, such
as somatic mutations, to provide potential candidates of targeted therapy. The
identification of these aberrations from sequencing noise and germline variant
background poses a classic classification-style problem. This has been previously
broached with many different supervised machine learning methods, including
deep-learning neural networks. However, these neural networks have thus far not
been tailored to give any indication of confidence in the mutation call, meaning an
oncologist could be targeting a mutation with a low probability of being true. To
address this, we present here a deep bayesian recurrent neural network for cancer
variant calling, which shows no degradation in performance compared to standard
neural networks. This approach enables greater flexibility through different priors
to avoid overfitting to a single dataset. We will be incorporating this approach into
software for oncologists to obtain safe, robust, and statistically confident somatic
mutation calls for precision oncology treatment choices.
1 Introduction
Cancer is a group of diseases that result from specific changes in the genetic code of otherwise
healthy cells. These changes vary from DNA point mutations and insertion/deletion mutations,
to copy number aberrations and structural variants. Next generation DNA sequencing (NGS) is
now commonly used in clinical practice to identify genetic variants, with oncologists using this
information for, among other things, determining the best treatment strategy.
However, variants can be difficult to interpret due to deconvolution of cancer (somatic) mutations
from heritable (germline) variants, and sequencing error. As a tumor is the product of an accumulation
of mutations over time, mutations can be found in anywhere from 0-100% of the sequencing reads in
a tumor, and overlap with the germline variant frequencies and the error rate from the sequencing
process. Machine learning approaches have been previously used to classify somatic mutations from
germline or error [1]. However, neural networks in this space have thus far not been tailored to give
any indication of confidence in mutation calls, meaning an oncologist could be targeting a mutation
with a low probability of being real. We aim to build upon previous approaches by providing a more
informative output, including probability that the classification is correct.
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For this, we present the use of Bayesian Neural Networks (BNNs) for somatic variant calling in
cancer. Augmenting a bayesian inference approach with the power provided by standard NNs. The
goal of a BNN is to learn a posterior probability density function (pdf) over the space W of the
weights. This is contrary to a standard NN, where one tries to make point estimations via maximum
likelihood. This usually implies overfitting. Overfitting in a standard NN can be relaxed for example
using regularization, that from a probabilistic point of view is equivalent to introducing some prior on
the weights.
Instead of dealing with point estimates, BNNs try to learn entire probability distributions. This
implies that with respect to standard NNs we have a measure of uncertainty, making the overall
network more robust in its predictions, and giving it the ability to say ’I do not know’. This is an
important property for decision making.
In this study, we utilize BNNs to provide oncologists with probability values of mutation calls, to
better inform them during treatment selection, without impacting performance.
2 Variant Calling
2.1 The Task
NGS produces overlapping short sequences of DNA called reads. For a fixed position in a sequenced
genome we can find a number of reads coming either from different cells or duplication of an original
DNA strand. We call this number the depth. When, for a given patient, we sequence both tumor
and normal tissues for comparison, we expect to see a number of true somatic variants (in the tumor
tissue but not in the normal tissue), although the vast majority of the variations observed are due to
sequencing noise. Our aim is to provide an indication of confidence in the differentiation of somatic
variants from germline variants and error.
2.2 The Data
We process the initial raw data using a bioinformatics pipeline that identifies genomic loci where
sequencing data from the tumor significantly differs from the normal. We extract the data in the
following form:
pair =
 N11 . . . N1w T11 . . . T1w... . . . ... ... . . . ...
Nd1 . . . Ndw Td1 . . . Tdw

d : the depth
w : the width or number of observed loci
Nij : the normal base at position i and depth d
Tij : the tumor base at position i and depth d Figure 1: A visual representation of the pair ma-
trix with w = 10 and d = 100
2.3 The Labels
For training, we used the Multi-Center Mutation Calling in Multiple Cancers (MC3) high confidence
variant dataset [2]. The labels for this dataset are binary: 1 if the variant is validated positive, 0 if the
variant is validated negative. We did not include non-validated data.
3 Methods and Results
The input data is the aforementioned pair matrices with a specific size of (100, 20) with three color
channels. We reshape the input data from (100, 20, 3) to (100, 60), diluting the color information to
analyze using LSTMs. The dataset is also unbalanced, which we correct through undersampling of
the majority class. This resulted in a total of 103868 (image, label) pairs. For these data we used a
0.8 training-test split.
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We implemented two models: the first including two layers of bidirectional LSTMs and two dense
layers, and the second with variational dense layers. We have used DenseFlipout layers provided
by the Tensorflow Probability library (tfp)[3]1. Adam optimizer [4] was used to optimize the cost
function of each network. The usefulness of using variational layers, during training with data D, is
to learn an approximate probability density function of the true, usually intractable, posterior p(~w|D)
for the weights of the network. As it is known, the Kullback–Leibler (KL) is loosely speaking a
measure of similarities between two probabilty functions. Therefore minimising it, with respect to
the parameters ~θ defining the approximate posterior, would allow us to approximate the true posterior.
We did this by minimizing a cost function defined as the negative of the ELBO (Evidence Lower
Bound) [5]
−ELBO = −EQ~w(~θ)log(P (D|~w)) +KL(Q~w(~θ)||p(~w)) (1)
where P (D|~w) and p(~w) are the likelihood of the data and the prior respectively for the weights ~w,
and Q~w(~θ) is an approximate pdf to the true posterior p(~w|D). Maximizing the ELBO is equivalent
to minimizing the KL divergence between the true posterior and the approximate posterior for the
weights. We will assume a multivariate gaussian for the variational posterior Q~w(~θ). Practically, as
the integrals in 1 are in general analytically intractable, they are computed via Monte Carlo (MC)
sampling from the approximate pdf Q~w(~θ). This is automatically done by the variational layers in tfp.
Secondly, as it is costly to calculate the ELBO for large datasets such as those in DNA sequencing,
tfp allows to do automatically minibatch optimization. Therefore, 1 is calculated as an average over
many ELBOs calculated on batches of data Dk with sampled weights ~wi. This approximation is
an unbiased stochastic estimator for the ELBO[5]. As a result, the calculated gradient will not be
miscalculated, allowing convergence to the correct solution.
The usefulness of the Flipout estimator [6] in the layers is that the unbiased estimation of the ELBO
has lower variance with respect to other methods. This is an important point, as the variance of the
ELBO dictates the convergence of the optimization process during training. After learning the pdf
Q~w(~θ) ∼ p(~w|D) for the weights, via ELBO optimization, we make a new prediction y∗ with a new
X∗ datum, by calculating:
p(y∗) =
∫
d~wp(y∗|X∗, ~w)p(~w|D) (2)
This is done in practice by Monte Carlo sampling, where we substitute the integral with an averaged
sum over weights sampled from the approximate posterior, to make a prediction from a network in an
ensemble of networks, and then taking the average
pˆ(y∗) =
1
NMC
∑
~wk∼Q~w(~θ)
p(y∗|X∗, ~wk) (3)
In a classification problem, this means that for each possible outcome y∗ ∈ A, where A is the set of
all outcomes, we will calculate this estimate pˆ(y∗), ensuring that
∑
y∗∈A pˆ(y
∗) = 1.
As one of our goals was to check performance degradation, we trained the standard and Bayesian
NNs without hyperparameters optimization. We reached a training sparse categorical accuracy of
0.76 and 0.78 for the standard NN and BNN respectively, with a 0.75 accuracy on the test set for
both. The standard model does not provide confidence in any given result, while the BNN provides a
measure of uncertainty. Utilizing the probabilities for each BNN outcome y∗ given the input datum
X∗, we can generate a ’confidence’ measure of the prediction, given by the probability. We show in
Figure 2 how the confidence is degraded when a black mask has been artificially added on the input
images making the input distribution different than those seen during training. The BNN becomes
uncertain for out of distribution samples.
1https://github.com/tensorflow/probability
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Figure 2: Sample of results produced by our Bayesian LSTM applied to original data (left) and
masked data (right).
For a better understanding of the BNN behavior we tested our model on both in-distribution and
out-of-distribution samples. The results are summarized in Figure 3, where we plot the frequency
of the probabilities that the network output for each sample. For the first case, we see clearly a
skewed distribution, with a dip in the middle. This means that the BNN is somewhat certain about its
predictions. While for the second case, on the right, we observe that output probabilities are mostly
around 0.5, showing that the model is uncertain.
Figure 3: Histograms of the output probabilities from the BNN tested on in-distribution samples (left)
and masked data that are out-of-distribution (right).
4 Conclusions
The main results of this paper include: the discovery that BNNs do not degrade the performance
of standard NNs in this application, whilst outputting useful probabilities; BNNs enable detection
of distribution samples without additional work. Although BNNs are computationally expensive
compared to standard NNs, they are more flexible and one can choose different priors or likelihoods
to suit the input data, and give naturally regularizing terms (the KL term in 1) to avoid overfitting.
In conclusion, the methods provided herein display a promising novel deep Bayesian neural network
methodology for improving genetic variant identification. As a useful approach in providing confi-
dence metrics on neural network derived somatic variant calls, we hope that these methodologies
will help clinicians make more informed and better treatment decisions, and eventually show clinical
impact in the advancement of precision oncology.
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